Lofexidine Clinical Trials
3 recruitingDrug
Phase 23
Showing 1–3 of 3 trials
Recruiting
Phase 2
Evaluating Buspirone to Treat Opioid Withdrawal
University of Maryland, Baltimore100 enrolled1 locationNCT05511909
Recruiting
Phase 2
Assessing a Clinically-meaningful Opioid Withdrawal Phenotype
Opioid Withdrawal
University of Maryland, Baltimore60 enrolled1 locationNCT05027919
Recruiting
Phase 2
Lofexidine Combined With Buprenorphine for Reducing Symptoms of PTSD and OU Relapse in Veterans
Post Traumatic Stress DisorderOpioid-use Disorder
Pharmacotherapies for Alcohol and Substance Use Disorders Alliance120 enrolled2 locationsNCT04360681